Clinical Trial Update: Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assesses whether thiazolidinedione drugs (glitazones) influence HDL-mediated vasodilation in individuals with type 2 diabetes, potentia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED